MEREDITH JULIAN: Open Payments
NPI 1669917696 · GROTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 30 payments from 11 companies in 2025. Trend: 2023 $1,248 · 2024 $1,213 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $152 |
| Amgen Inc. | 8 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $134 |
| Janssen Biotech, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| Sandoz Inc. | 1 | $23 |
| UCB, Inc. | 1 | $17 |
Products named: BENLYSTA, ENBREL, FARXIGA, BREZTRI, TREMFYA, ORENCIA, AIRSUPRA, MOUNJARO.
Industry payments across MA — which companies pay providers there.
